Skip to main content

Month: May 2020

Rubicon Organics Announces $10 Million Private Placement

VANCOUVER, British Columbia, May 19, 2020 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (CSE:ROMJ) (OTCQX:ROMJF) (“Rubicon Organics” or the “Company) is pleased to announce a non-brokered private placement of units of the Company (“Units”) at a price of $2.35 per Unit for gross proceeds of up to $10 million (the “Offering”). Each Unit shall be comprised of one common share of the Company (each, a “Common Share”) and one Common Share purchase warrant of the Company (each, a “Warrant”). Each Warrant shall entitle the holder thereof to acquire one Common Share at a price of $3.25 per Common Share at any time during the 12-month period following the closing date of the Offering.The Company intends to use proceeds from the Offering for optimization of its Delta, BC facility (including a lights upgrade and outdoor grow), the launch of cannabis...

Continue reading

REPEAT: NuLegacy Gold Announces C$5.625 Million Private Placement

VANCOUVER, British Columbia, May 19, 2020 (GLOBE NEWSWIRE) — NuLegacy Gold Corporation (“NuLegacy” or the “Company”) (TSXV: NUG; OTCQB: NULG.F) announces that it has arranged a non-brokered private placement of up to 75,000,000 units (the “Units”) at a price of C$0.075 per Unit to raise gross proceeds to the Company of C$5.625 million (the “Offering”).Each Unit will consist of one common share of the Company (a “Common Share”) and one-half of one transferable Common Share purchase warrant (each full warrant, a “Warrant”). Each Warrant will entitle the holder to acquire one Common Share of the Company at an exercise price of C$0.125 for a period, subject to acceleration, of 24 months following closing of the Offering.NuLegacy’s CEO Albert Matter comments that “Our recent winter 2019 drill program and subsequent analysis and geological...

Continue reading

Novoheart Holdings Inc. Reports First Quarter 2020 Financial Results and Announces AGM Results

VANCOUVER, British Columbia, May 19, 2020 (GLOBE NEWSWIRE) — Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three months ended March 31, 2020. Amounts, unless specified otherwise, are expressed in Canadian dollars and are in accordance with International Financial Reporting Standards (IFRS).

Continue reading

NIO Inc. to Report First Quarter 2020 Financial Results on Thursday, May 28, 2020

SHANGHAI, China, May 19, 2020 (GLOBE NEWSWIRE) — NIO Inc. (“NIO” or the “Company”) (NYSE: NIO), a pioneer in China’s premium smart electric vehicle market, today announced that it will report its first quarter 2020 unaudited financial results on Thursday, May 28, 2020, before the open of the U.S. markets.The Company’s management will host an earnings conference call at 8:00 AM U.S. Eastern Time on May 28, 2020 (8:00 PM Beijing/Hong Kong Time on May 28, 2020).Please register in advance of the conference using the link provided below and dial in 10 minutes prior to the call, using participant dial-in numbers, Direct Event passcode and unique registrant ID which would be provided upon registering.http://apac.directeventreg.com/registration/event/8574289Additionally, a live and archived webcast of the conference call will be available...

Continue reading

CytoDyn and the Mexican National Institutes of Health Participate in a Collaborative Study of Leronlimab for the Treatment of Severe/Critical COVID-19 Population

 The study is anticipated to consist of approximately thirty patients with potential involvement of the NIH of Mexico in other CytoDyn trialsVANCOUVER, Washington, May 19, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced it will be coordinating with the NIH of Mexico and providing leronlimab for a trial for the severe/critical COVID-19 population in Mexico with the potential to collaborate on further CytoDyn COVID-19 trials. CytoDyn is currently enrolling a Phase 2b/3 clinical trial for 390 patients, which is a randomized, placebo-controlled with 2:1 ratio (active drug to placebo ratio). CytoDyn is also enrolling a Phase 2 randomized clinical...

Continue reading

Network Security Market to Rise at 11.6% CAGR till 2027; Increasing Internet Penetration Will Create a Huge Demand for the Product, says Fortune Business Insights™

Pune, May 19, 2020 (GLOBE NEWSWIRE) — The global network security market size is projected to reach USD 54.07 billion by the end of 2027. Increasing number of cybercrime activities will have a major impact on the growth of the overall market in the coming years. According to a report published by Fortune Business Insights, titled “Network Security Market Size, Share & Industry Analysis, By Type(Firewalls, Antivirus and antimalware software, VPN, Data loss prevention, Intrusion prevention systems, Wireless security, Others (Email security, Application security etc.), By Enterprise Size (SMEs and Large Enterprises), By Deployment (Cloud, On-premises), By Industry (BFSI, IT and Telecommunications, Retail, Healthcare, Government, Manufacturing, Travel and Transportation, Energy and Utilities and Others (Education, etc.,.)), and...

Continue reading

iQSTEL, Inc. Secures China Mobile Network Interconnection Partnership Through QGlobal SMS

NEW YORK, NY, May 19, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — iQSTEL Inc. (OTC: IQST) is pleased to announce QGlobal SMS has secured a partnership deal with China Mobile (a NYSE traded company) to facilitate the business exchange between iQSTEL and China Mobile.iQSTEL’s product portfolio continues to grow with VoIP, SMS, 5G, blockchain-based platforms and Internet of Things (IoT). In addition, our carrier network interconnect deals continue to expand globally and now are set to include Asia through our new partnership with China Mobile.China Mobile is the world’s largest mobile telecommunications company by subscriber numbers at almost 1 Billion, covering China and Hong Kong as well as Pakistan and some services targeted at Chinese citizens in the UK. A natural progression for China Mobile’s expansion as the Latin American...

Continue reading

Notice of Annual General Meeting from the Board of Directors of Vestjysk Bank A/S

Nasdaq Copenhagen A/S19 May 2020IMPORTANT NOTICE IN RELATION TO COVID-19:In order to protect the health and safety of all and given the Danish government’s restrictions on assembly, the Bank calls on shareholders to, at the widest extent possible, make use of the possibility to give proxy or vote by correspondence instead of attending in person. If shareholders choose to attend the general meeting in person, the Bank encourages shareholders not to bring a guest/adviser.In order to limit the number of participants at the general meeting, the Bank will be represented by the Chairman and Deputy Chairman of the Board of Directors as well as the CEO.There will not be served any refreshments at the General Meeting.Notice from the Board of Directors of Vestjysk Bank A/S to convene the Annual General MeetingThe Annual General Meeting is held...

Continue reading

Bestyrelsen i Vestjysk Bank A/S indkalder til ordinær generalforsamling

Nasdaq Copenhagen A/S19. maj 2020VIGTIG MEDDELELSE I RELATION TIL COVID-19:Af hensyn til alles sikkerhed og regeringens forsamlingsforbud opfordrer banken til, at aktionærer i videst muligt omfang benytter sig af muligheden for at afgive fuldmagt eller brevstemme forud for generalforsamlingen frem for fysisk fremmøde. Såfremt aktionærer vælger at møde fysisk opfordrer banken til, at aktionærer ikke medtager ledsager/rådgiver.Med henblik på at begrænse det fysiske deltagerantal til generalforsamlingen vil der fra bankens side være deltagelse fra bestyrelsens formand og næstformand samt den administrerende direktør.Der vil ikke være forplejning på generalforsamlingen.Bestyrelsen i Vestjysk Bank A/S indkalder til ordinær generalforsamlingGeneralforsamlingen afholdes onsdag den 10. juni 2020, kl. 15.00, i Lemvig ldræts- & Kulturcenter,...

Continue reading

Oxford Immunotec releases the T-SPOT® Discovery™ SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2, which may offer new insights into immunity to COVID-19

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 19, 2020 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announces the release of the T-SPOT Discovery SARS-CoV-2 test kit. This kit is for research use only and launched under the T-SPOT Discovery brand. This research kit could make a significant contribution towards development of a new tool to manage the COVID-19 pandemic, which in turn could help to bring nations out of their current lockdowns in a faster, safer and more controlled manner.T-SPOT Discovery SARS-CoV-2 builds on Oxford Immunotec’s experience with TB diagnosis and the assessment of immune response to CMV in transplant patients, to apply the Company’s established, proprietary T-SPOT technology to the fight against COVID-19. While serology...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.